患有严重心脏病的癌症病人面临较高的死亡风险,但治疗却削减了72%,敦促进行常规心脏检查。 Cancer patients with severe heart valve disease face higher death risk, but treatment cuts it by 72%, urging routine heart checks.

一项对10,000多名癌症患者的研究发现,7. 2%患者患有严重的心脏膜疾病,主要是三管或心肌吐和大动脉狭窄,与较高的死亡率和心血管死亡率有关. A study of over 10,000 cancer patients found 7.2% had severe valvular heart disease, mainly tricuspid or mitral regurgitation and aortic stenosis, linked to higher death and cardiovascular mortality rates. 只有21.5%的人接受了外科手术或切除术治疗,但那些确诊者的死亡风险却低72%。 Only 21.5% received surgical or transcatheter treatments, but those who did had a 72% lower risk of death. EACVI 2025年的研究结果强调必须对癌症患者进行常规心脏监测,并对避免阀门干预提出挑战,呼吁就癌症疗法如何影响心脏阀门开展更多的研究。 Findings presented at EACVI 2025 stress the need for routine heart monitoring in cancer patients and challenge avoidance of valve interventions, calling for more research on how cancer therapies affect heart valves.